Cohort from Netherlands 400+ PsA pts IR first bioDMARD 300+ switched TNFi->IL-17i, 99 cycled TNFi->TNFi 3year retention rates 12 mo 75% cyclers 80% swappers 24mo 60% cyclers 56% swappers No difference in treatment failure or DAS28 CRP #EULAR2024 @RheumNow POS0278 https://t.co/J8ONjVAFqG

• https://twitter.com/AurelieRheumo/status/1801520487605911565/photo/1

#EULAR2024 OP0193 Watch out, blinatumomab will BiTE! Bi-specific T-cell engagers (BiTEs), kill Bcells by engaging Tcells. In 6 refractory #RA patients (failed 3 x ts/bDMARDs), deep blood & tissue depletion were met, good response. Brief raised temp but no cytokine storm @RheumNow https://t.co/OmxSbTXfZq

• https://twitter.com/Yuz6Yusof/status/1801644379829879176/photo/1
• https://twitter.com/Yuz6Yusof/status/1801644379829879176/photo/1

RA patients on abatacept have an appalling immunogenic response to Shingrix. Humoral fades away in the first year, and an absence of cellular responses. Alarming and need strategies to combat this #EULAR2024 POS0620 Winthrop/@RADoctor @RheumNow https://t.co/8gY9ocLBDp

• https://twitter.com/drdavidliew/status/1801641070629109908/photo/1

#opportunistic inf in #autoimmune dz 🎤 @khyrich 👉#herpes zost is ⬆️⬆️,esp😳#lupus (💉 >18yo🇺🇸) 👉#HBV react ⬆️⬆️ w/ RTX (9.1%) >>TNFi, JAKi, IL-6 👉 🙅‍♂️ #TB repeat 🧪 on #DMARD if 🚫new risk fact/gap⚠️ 🔗#eular 2022 guide: https://t.co/PIpGpTrH28 #eular2024 #rheumx @RheumNow https://t.co/kouXvradiC

• https://ard.bmj.com/content/annrheumdis/82/6/742.full.pdf
• https://twitter.com/AMinalyan/status/1801606024576565284/photo/1
• https://twitter.com/AMinalyan/status/1801606024576565284/photo/1
• https://twitter.com/AMinalyan/status/1801606024576565284/photo/1
• https://twitter.com/AMinalyan/status/1801606024576565284/photo/1

Approach to TB screening prior to commencing biologics. Hyrich K #EULAR2024 @RheumNow https://t.co/j3PI0PHpqW

• https://twitter.com/synovialjoints/status/1801596567758967036/photo/1

Cycle or swap 2? Post failure to a first TNFi in patients with PsA, there was no difference in cycle versus swap to IL17i for drug retention rate or disease activity. In male PsA patients a cycle strategy had a longer drug retention rate compared to a swap (IL-17i) strategy.… https://t.co/5BykvDwFWV https://t.co/GfcnIltV2A

• https://twitter.com/i/web/status/1801590870908518546
• https://twitter.com/synovialjoints/status/1801590870908518546/photo/1

#EULAR2024 Please find our Day 1 & Day 2 Recap of selective abstracts/research presented at the conference 😃@RheumNow @DrMiniDey https://t.co/AHl18gS7gF https://t.co/LEoa9rBNly

• EULAR 2024 Daily Recap: Days 1 & 2
• https://twitter.com/Yuz6Yusof/status/1801555153968882024/photo/1